Angelo Antonini (University of Padova, Veneto, Italy), one of our valued European editorial board members, discusses impulse control disorders in patients with Parkinson’s disease including findings related to these behaviours in the Parkinson’s Disease Real-World Impact Assessment (PRISM) study.
1. What are the major impulse control disorders seen in patients with Parkinson’s disease and what is their prevalence? (0:05) 2. Could you tell us a little about the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study and its findings in terms of impulse control behaviours? (1:59)
Also see linked video: Angelo Antonini, EAN 2020 – Definition and Management of Advanced Parkinson’s Disease
Speaker disclosure: Angelo Antonini has received honoraria for consultancies, advisory boards and/or speaker activities from: AbbVie, Bial, Boehringer Ingelheim, General Electric, NeuroDerm, UCB and Zambon. He has received research support from: Chiesi, Lundbeck, AbbVie, Horizon 2020 and MIUR.
Support: Interview and filming supported by Touch Medical Media.
Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson’s disease. He particularly focusses on new insights in early detection of the disease before motor symptoms […]
Highlights from EAN 2023!
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!